PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E952. A total of 3 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,160 | +85.8% | 12,000 | +207.7% | 0.00% | – |
| Q2 2023 | $107,718 | -80.1% | 3,900 | -83.4% | 0.00% | -100.0% |
| Q1 2023 | $540,500 | +0.7% | 23,500 | -65.4% | 0.00% | +100.0% |
| Q2 2022 | $537,000 | -56.2% | 67,900 | +31.1% | 0.00% | 0.0% |
| Q1 2022 | $1,227,000 | +12170.0% | 51,800 | +17166.7% | 0.00% | – |
| Q4 2021 | $10,000 | -63.0% | 300 | -50.0% | 0.00% | – |
| Q2 2021 | $27,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,000 | $200,160 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 300 | $5 | 0.00% |